Invitrogen™ Human TDP-43 Synthetic Peptide

Ref.: BL-RE-177021Manufacturer ref.: PEP-0526 50 μg
€150.00 excl. VAT

TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.

Gene ID (Enter)
23435
Species
Human
Purification method
Purified
Accession number
Q13148
Common name
Human TDP-43
Brand
Invitrogen

TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.

TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.

TDP43 was first identified as a novel cellular protein that binds to HIV-1 virus TAR DNA sequence motifs and acts a transcriptional repressor to the HIV-1 LTR. Later experiments revealed that TDP43 also regulates the splicing of exon 9 of the cystic fibrosis transmembrane conductance regular (CFTR), most likely through the association with the UG repeats at the 3'e; splice site. A hyperphosphorylated, ubiquitinated, and cleaved form of TDP43 known as pathologic TDP43 is the major disease protein in ubiquitin-positive, tau-, and alpha-synuclein-negative frontotemporal dementia (FLTD-U). TDP43 is not related to TRBP1, and RNA binding protein that binds HIV-1 TAR RNA sequences.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15338650
Specifications
Gene ID (Enter)23435
SpeciesHuman
Purification methodPurified
Accession numberQ13148
Common nameHuman TDP-43
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TARDBP
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0526
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.